PER3, a novel target of miR-103, plays a suppressive role in colorectal cancer in vitro

被引:46
|
作者
Hong, Zhang [1 ]
Feng, Zhang [2 ]
Sai, Zhang [3 ]
Tao, Su [3 ]
机构
[1] Cent South Univ, Xiangya Hosp, Nurse Dept Organ Transplantat, Changsha 41008, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Sch Med, Changsha 41008, Hunan, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Inst Med Sci, Changsha 41008, Hunan, Peoples R China
关键词
Circadian clock gene; Colorectal cancer; miR-103; Period3; Vitro; CIRCADIAN CLOCK; INVASION; METASTASIS; EXPRESSION; P53;
D O I
10.5483/BMBRep.2014.47.9.212
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Colorectal cancer has become the third most common cancer and leads to high mortality worldwide. Although colorectal cancer has been studied widely, the underlying molecular mechanism remains unclear. PER3 is related to tumor differentiation and the progression of colorectal cancer. High expression of miR-103 is associated with poor prognosis in patients with colorectal cancer. However, the relationship between miR-103 and PER3 in CRC cells remains unclear. In this study, we found that PER3 was downregulated in CRC tissues and CRC cell lines, whereas miR-103 was upregulated in CRC cell lines. We also found that PER3 promoted CRC cells apoptosis. These results indicate that PER3 plays a suppressive role in CRC cells. Moreover, we found that PER3 was targeted, at least partially, by miR-103. Taken together, we provide evidence to characterize the role of PER3 in CRC, which may be a new therapeutic target for CRC.
引用
收藏
页码:500 / 505
页数:6
相关论文
共 50 条
  • [41] SYT12 plays a critical role in oral cancer and may be a novel therapeutic target
    Eizuka, Keitaro
    Nakashima, Dai
    Oka, Noritoshi
    Wagai, Sho
    Takahara, Toshikazu
    Saito, Tomoaki
    Koike, Kazuyuki
    Kasamatsu, Atsushi
    Shiiba, Masashi
    Tanzawa, Hideki
    Uzawa, Katsuhiro
    JOURNAL OF CANCER, 2019, 10 (20): : 4913 - 4920
  • [42] MiR-103a-3p Contributes to the Progression of Colorectal Cancer by Regulating GREM2 Expression
    Zhang, Zongxiang
    Zhu, Xiaolian
    YONSEI MEDICAL JOURNAL, 2022, 63 (06) : 520 - 529
  • [43] Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/ FOXO1 pathway
    Wan Li
    Jie Yi
    Xiangjin Zheng
    Shiwei Liu
    Weiqi Fu
    Liwen Ren
    Li Li
    Dave S. B. Hoon
    Jinhua Wang
    Guanhua Du
    Clinical Epigenetics, 16 (1)
  • [44] Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway
    Wan Li
    Jie Yi
    Xiangjin Zheng
    Shiwei Liu
    Weiqi Fu
    Liwen Ren
    Li Li
    Dave S. B. Hoon
    Jinhua Wang
    Guanhua Du
    Clinical Epigenetics, 2022, 14
  • [45] DCLK1 plays an important role in colorectal cancer tumorgenesis through the regulation of miR-200c
    Mohammadi, Yasaman
    Tavangar, Seyed Mohammad
    Saidijam, Massoud
    Amini, Razieh
    Etemadi, Katayoon
    Dermani, Fatemeh Karimi
    Najafi, Rezvan
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 103 : 301 - 307
  • [46] Molecular Pathogenesis of Colorectal Cancer: Impact of Oncogenic Targets Regulated by Tumor Suppressive miR-139-3p
    Yasudome, Ryutaro
    Seki, Naohiko
    Asai, Shunichi
    Goto, Yusuke
    Kita, Yoshiaki
    Hozaka, Yuto
    Wada, Masumi
    Tanabe, Kan
    Idichi, Tetsuya
    Mori, Shinichiro
    Ohtsuka, Takao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [47] A novel HIF1AN substrate KANK3 plays a tumor-suppressive role in hepatocellular carcinoma
    Kim, Iljin
    Kang, Jengmin
    Gee, Heon Yung
    Park, Jong-Wan
    CELL BIOLOGY INTERNATIONAL, 2018, 42 (03) : 303 - 312
  • [48] Circ_0000218 plays a carcinogenic role in colorectal cancer progression by regulating miR-139-3p/RAB1A axis
    Pei, Fu-Lai
    Cao, Ming-Zheng
    Li, Yue-Feng
    JOURNAL OF BIOCHEMISTRY, 2020, 167 (01): : 55 - 65
  • [49] The role of NLRP3 inflammasome in colorectal cancer: potential therapeutic target
    Vafaei, Somayeh
    Taheri, Hamed
    Hajimomeni, Yasamin
    Yaseri, Amirhossein Fakhre
    Zadeh, Firoozeh Abolhasani
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (10): : 1881 - 1889
  • [50] The role of NLRP3 inflammasome in colorectal cancer: potential therapeutic target
    Somayeh Vafaei
    Hamed Taheri
    Yasamin Hajimomeni
    Amirhossein Fakhre Yaseri
    Firoozeh Abolhasani Zadeh
    Clinical and Translational Oncology, 2022, 24 : 1881 - 1889